A Study to Evaluate MAR002 for Acromegaly
Public ClinicalTrials.gov record NCT07641179. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo- Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MAR002 in Participants With Acromegaly (TROUGH-2)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in participants with acromegaly
Study identification
- NCT ID
- NCT07641179
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 72 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2026
- Primary completion
- Jul 31, 2027
- Completion
- Nov 30, 2027
- Last update posted
- Aug 23, 2026
2026 – 2027
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center | Phoenix | Arizona | 85013 | Recruiting |
| Endocrinology Associates, Inc | Columbus | Ohio | 43201 | Recruiting |
| Consano Clinical Research | San Antonio | Texas | 78258 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Acromegaly trials
Other public records listing Acromegaly. Sorted by last update posted; newest first. Not a recommendation.
- NCT05192382: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) Active, not recruiting
- NCT04837040: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly Active, not recruiting
- NCT06930625: A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs Recruiting
- NCT07037420: ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly Recruiting
- NCT07195175: Study of MAR002 in Healthy Men Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07641179, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2026 · Synced Aug 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07641179 live on ClinicalTrials.gov.